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Assessment of the effect of clonidine on depth of anaesthesia is dif®cult because clonidine
combines analgesic, sedative and direct haemodynamic effects. We thus evaluated the in¯uence
of clonidine on the bispectral index (BIS) and its potential dose-sparing effect on propofol.
After induction of anaesthesia with target-controlled infusion of propofol and obtaining an
unchanged bispectral index (pre-BIS), clonidine 4 mg kg±1 or placebo was administered
randomly to 50 patients in a double-blind manner. Subsequently, if there was a decrease in BIS
we reduced the target concentration of propofol until pre-BIS was reached. The pre-BIS was
maintained and a remifentanil infusion was added during surgery. The courses of the BIS, heart
rate and blood pressure were recorded and the total amounts of intra-operative propofol and
remifentanil were determined. Assessment of implicit memory during anaesthesia was
performed with an auditory implicit memory test consisting of item sequences. Administration
of clonidine resulted in a decrease in the BIS from 45 (SD 4) to 40 (6) (P<0.001), which allowed
a reduction of propofol target concentration from 3.3 (0.6) to 2.7 (0.7) mg ml±1 (P<0.001) and
measured propofol concentration from 2.9 (0.6) to 2.5 (0.7) mg ml±1 (P=0.009) in order to
maintain the pre-BIS value. During subsequent surgery, propofol requirements were reduced
by 20% (P=0.002) in the clonidine group and a similar amount of remifentanil was used in each
group. The increase in anaesthetic depth given by clonidine can therefore be measured with
bispectral EEG analysis and allows reduction of the propofol dose to achieve a speci®c depth of
anaesthesia.
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Clonidine, a centrally acting a2-receptor agonist, has
attracted increasing interest as an adjunct to anaesthesia.
A variety of bene®cial effects before, during and after
anaesthesia, such as sedation, analgesia, increased cardio-
vascular stability and improved outcome, have been attrib-
uted to clonidine.1 2 Clonidine reduced the requirement for
volatile anaesthetics when assessed by haemodynamic
responses.3 4 Imai found that a reduced dosage of propofol
was required after administration of clonidine,5 whereas
Goyagi found a reduced induction but not maintenance dose
of propofol when using haemodynamic end-points.6
However, assessing anaesthetic depth by the use of
haemodynamic variables after administration of clonidine,
which depresses autonomic nervous system responses, is
fraught with dif®culties. A lack of tachycardia or hyperten-
sion does not necessarily indicate an adequate depth of
anaesthesia. Because centrally acting a2-receptor agonists
have effects on the EEG and the bispectral index (BIS) in
the awake patient, we thought that the effect of clonidine on
depth of anaesthesia might also be monitored using the
BIS.7 8 This study was conducted to evaluate ®rst whether
the sedative effect of clonidine is measurable by BIS
analysis during propofol anaesthesia, and secondly whether
BIS monitoring allows the maintenance of a constant
anaesthetic depth despite a reduced propofol dosage after
administration of clonidine.
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Materials and methods
This randomized, double-blind, placebo-controlled study
was designed to test the hypothesis that clonidine deepens
anaesthesia as measured by the BIS and allows the dose of
propofol to be reduced.
After obtaining institutional review board approval and
written informed consent, we studied 50 German-speaking
patients, aged 18±70 yr, American Society of
Anesthesiologists physical status I or II, scheduled for
super®cial surgical procedures expected to last at least
45 min. Patients with cardiopulmonary, neuropsychiatric or
hearing disorders and patients taking any medication
affecting cardiovascular or neurological function were
excluded. Patients received no premedication.
After admission of the patients to the operating room, an
i.v. cannula was placed and standard monitoring was
established. In addition, the level of consciousness was
surveyed by bispectral EEG analysis (Aspect A-1000 EEG
monitor, software module 3.12; Aspect Medical Systems,
Natick, MA, USA) and expressed as the BIS. After
preparation of the skin, four disposable, self-prepping,
low-impedance electrodes (Zipprep; Aspect Medical
Systems) were positioned over the left and right prefrontal
cortex (Fp1, Fp2) and referenced to a central vertex
electrode (Cz) according to a standard montage.
Impedances were kept at less than 5000 W.
Anaesthesia was induced by propofol infusion using a
target-controlled infusion (TCI) pump (Graseby 3500;
Graseby Medical, Watford, UK). The target plasma con-
centration of propofol (mg ml±1) was raised in incremental
steps until the patient became unconscious, as de®ned by the
loss of the eyelash re¯ex. The corresponding BIS was
recorded. To intubate the trachea, anaesthesia was deepened
by increasing the target plasma concentration of propofol
and muscle paralysis was achieved with rocuronium
0.6 mg kg±1. During the whole procedure, the patients'
lungs were ventilated with 40% oxygen in air. The target
plasma concentration of propofol was adjusted to achieve a
constant level of anaesthesia, indicated by a BIS corres-
ponding to the BIS at loss of eyelash re¯ex (pre-BIS). The
target concentration of propofol was adjusted in steps of
0.1±0.5 mg ml±1. A steady state was assumed only when the
calculated effect site concentration equalled the target
plasma concentration.
Keeping the propofol target concentration constant, we
allocated the patients randomly to receive either an infusion
of clonidine 4 mg kg±1 or placebo in 0.9% NaCl 100 ml
during the following 10 min. If the BIS was altered 15 min
after the end of infusion, the target plasma concentration of
propofol was reduced until the pre-BIS value was reached
(Fig. 1). Heart rate, arterial blood pressure, the BIS and
target plasma concentration of propofol were recorded
every 2 min. Blood samples for measuring the blood
concentration of propofol were taken via an additionally
established 14 G cannula in a large vein on the contralateral
arm before (`pre' phase) and 15 min after clonidine or
placebo infusion (`hold' phase) and after adjusting the
propofol target concentration (`post' phase), to achieve a
steady state, de®ned as a constant BIS (= pre-BIS 63) over a
period of at least 5 min. The blood samples (4 ml
heparinized tubes) were stored immediately at ±20°C and
analysed by high-performance liquid chromatography with
¯uorescence detection.9
During the surgery, supplementary analgesia was pro-
vided by remifentanil infusion at a rate between 0.01 and
1 mg kg±1 min±1 to maintain an unchanged BIS and
haemodynamic stability (Fig. 2). The target concentration
of propofol was maintained unchanged unless the target BIS
(pre-BIS 65) could not be maintained by varying the
remifentanil infusion rate, and at the end of the operation to
allow a fast wake-up. Heart rate, arterial blood pressure,
BIS, propofol target concentration and remifentanil infusion
rate were recorded every 5 min during the intra-operative
course. Hypertension or hypotension (620% of the arterial
blood pressure in the `pre' phase) occurring with the BIS in
the target range or sudden and marked blood pressure
changes were scheduled to be treated with esmolol (20 mg)
Fig 1 Study design: preoperative examination. BIS?: after clonidine/placebo infusion, the BIS response was evaluated. With an unchanged BIS the
target plasma concentration of propofol (TCI) was maintained; when a decrease in the BIS was observed, the target plasma concentration of propofol
was reduced until the BIS was again at the pre-BIS level.
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or phentolamine (1 mg) respectively, ephedrine (5 mg) and
gelatin (500 ml). Simultaneously, remifentanil and propofol
dosing was adjusted in accordance with the study protocol
(Fig. 2). Atropine (0.5 mg) was administered if the heart rate
fell below 40 beats min±1. Plasma concentrations of
clonidine were analysed from blood samples 15 min
(`hold' phase) and 180 min after clonidine infusion and at
the end of surgery. Heparinized blood (6 ml) was placed on
ice immediately after sampling, centrifuged promptly at
+4°C to separate the plasma, and stored at ±20°C until
analysis by high-performance liquid chromatography. To
avoid clonidine redosing, the propofol-sparing ef®cacy was
assessed during the ®rst 180 min after clonidine adminis-
tration.
To assess implicit memory during anaesthesia, four
test items of different categories were presented to the
patients through headphones at the following time
points: immediately before (`pre' phase), 15 min after
(`hold' phase), after possible reduction of propofol
(`post' phase) and 180 min after infusion of clonidine
(or the end of the operation, whichever came ®rst). The
test items were selected in a pilot study in which 48
patients were asked to name 10 items from four
categories (animals, fruits, colours, countries). The
sequence in which these items were named was
recorded and we evaluated which item was named on
average in 10th position. These four items, named last
in each category, were selected to be presented to the
patients in the present study. On the post-operative day,
patients in the current study were asked to name 10
items in each category. The sequence in which these
items were named was again recorded. Scores of test
items (10 points for ®rst position, 9 points for second
position,. .. and 0 points for not mentioning the item at
all) were computed for each study time point (pre, hold,
post and intra-operative) to compare the clonidine and
placebo groups.10 Explicit memory was assessed by
asking for any free recall.
Statistical analysis
The duration of the different phases of the intra-operative
course and memory test items were analysed using the
Mann±Whitney U-test and Fisher's exact test. Repeated
measures analysis of variance with two within-group factors
[phase (pre, hold, post) and repetition (steady state values in
each phase)] and one between-group factor (clonidine/
placebo) and post hoc t-test with Bonferroni correction were
performed to evaluate differences in the progression of the
preoperative phases pre, hold and post. To analyse differ-
ences between phases (pre, hold post) within groups
(clonidine, placebo), paired t-tests with Bonferroni correc-
tion were used. Continuous data are presented as mean (SD).
P values less than 0.05 were considered signi®cant.
Results
The two groups were similar with regard to the physical
characteristics of the patients (Table 1) and the type of
operation. Times from the end of the preoperative exam-
ination to the start of the operation and the duration of
operation did not differ between the groups (Table 1).
Pre-operative measurements before and after
administration of clonidine
TCI values, BIS, measured propofol blood concentrations,
heart rate and mean arterial blood pressure were similar in
the two groups before starting the clonidine or placebo
infusion in the `pre' phase (Fig. 3). Fifteen minutes after the
infusion (hold phase), haemodynamic variables were still
Fig 2 Anaesthetic decision tree during the operation.
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similar between the groups but there was a signi®cant
decrease in heart rate in both groups (P<0.001). In the `hold'
phase, the BIS showed a signi®cant decrease in the
clonidine group (P<0.001) and was signi®cantly lower
than in the placebo group (P=0.002). After achieving pre-
BIS in the `post' phase, the clonidine group showed a
signi®cant decrease in the target propofol concentration
(P<0.001) and measured blood concentrations of propofol
(P=0.009), and a signi®cant decrease in heart rate and mean
arterial pressure (MAP) (P=0.002). In the `post' phase, the
target propofol concentration (P=0.002) and the measured
propofol blood concentrations (P=0.006) were signi®cantly
lower in the clonidine group than in the placebo group, but
similar BIS values (P=0.403) (Fig. 3) resulted. The meas-
ured plasma concentrations of clonidine were in the
therapeutic range [`hold' phase, 2.7 (0.8) ng ml±1; 180
min after clonidine administration or the end of operation,
1.7 (0.5) ng ml±1].
Intra-operative measurements
Throughout the intra-operative course, similar values for the
BIS were observed in the two groups. In the clonidine
group, this was achieved despite lower propofol target
concentrations and a reduced total propofol dosage
(Table 2). Interestingly, patients in both groups received
similar amounts of remifentanil (Table 2). Despite a
signi®cant decrease in mean intra-operative MAP, the
patients in the clonidine group needed similar amounts of
gelatin, atropine and ephedrine (Table 2). No patient was
treated with phentolamine or esmolol. The time to
extubation did not differ between the groups (Table 1).
Implicit and explicit memory analysis
There were no differences in age or gender between patients
in the pilot study and those in the current study [mean age:
pilot group 38 (18±75) yr; current group 38 (18±65) yr;
male/female 20/28 vs 23/27]. The scores for the presented
items were similar between the pilot study and the current
study and between the clonidine and the placebo groups at
all time points (P>0.05) (Fig. 4). No patient had any free
recall either of the presented items or of any other pre- or
intra-operative events.
Discussion
Intravenous clonidine results in a decrease in the BIS during
propofol anaesthesia and allows reduction of the target
concentration of propofol in order to maintain a certain BIS
level. The pharmacodynamic effect of clonidine during
anaesthesia can thus be monitored with the BIS.
Clonidine affects the EEG in a variety of ways: it
increases slow-wave activity (delta) and attenuates the
physiological alpha ¯uctuations.7 11 Although no data exist
regarding the speci®c effect of clonidine on the BIS,
clonidine causes sedation12 and therefore may also affect the
BIS,13 which indeed was demonstrated in the present study.
The propofol saving in the current study of nearly 20% is
comparable with earlier studies in which an iso¯urane
saving of approximately 40% was reported.14 15 The
somewhat greater iso¯urane saving in that study may be
explained by a different EEG analysis, a larger dose of
clonidine (5 vs 4 mg kg±1) and perhaps especially because
iso¯urane dosing was guided mainly by haemodynamic
responses. Another trial investigated the effect of clonidine
on i.v. anaesthesia with propofol and fentanyl and found a
reduction of approximately 40% in the propofol requirement
with similar doses of fentanyl after clonidine.5 Despite
similar anaesthetics and a relatively small dose of oral
clonidine (150 mg), this study revealed a greater reduction of
propofol in comparison with our study. This may be
explained by dosing propofol according to arterial blood
pressure and heart rate but without any monitoring of brain
function, such as the BIS.
Larger doses of clonidine may allow greater reductions in
anaesthetic drug use, but may lengthen the time required for
recovery from anaesthesia.6 This was not observed in the
present study and the time to extubation was similarly short
in the two groups. The restrictive propofol dosing in our
control group may be another reason for the relatively small
propofol saving compared with previous studies. This might
be linked to continuous monitoring of the BIS, which has
been reported to facilitate immediate recovery and to
decrease the consumption of anaesthetics.16
Clonidine administration resulted in a lower propofol
requirement for a certain level of anaesthesia to be achieved,
as de®ned by similar BIS values. The fact that no explicit
intra-operative awareness occurred and no signs of implicit
memory were observed indicates that the anaesthetic state
induced by clonidine and low-dose propofol may be similar
to the anaesthetic state induced by a larger dose of propofol
alone. It is evident that larger trials will be necessary to
show conclusively that a lower dose of propofol combined
with clonidine is as safe as a larger dose propofol in
preventing intra-operative awareness.
Table 1 Patient characteristics and operative times. Values are mean (SD) or
absolute count. Op. time=duration of operation; SO time=time from end of
pre-operative study phase to start of operation; Ext. time=time from end of
operation to extubation
Clonidine Placebo
(n=25) (n=25)
Age (yr) 38 (20±62) 39 (18±65)
Males 10 13
Weight (kg) 69 (13) 75 (14)
Height (m) 1.69 (0.11) 1.71 (0.07)
ASA I 22/25 22/25
ASA II 3/25 3/25
Op. time (min) 130 (70) 138 (83)
SO time (min) 40 (36) 46 (27)
Ext. time (min) 5 (7) 3 (5)
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We analysed the propofol concentration of venous
blood to avoid the insertion of an arterial catheter or
repeated arterial puncture. In addition, we ensured that
the time to steady state was always more than 10 min,
and thus arterial and venous propofol concentrations
should have been stable and in a ®xed ratio to each
other.17 Therefore, venous propofol concentrations may
be considered representative of the blood concentration
Fig 3 Propofol target plasma concentration (TCI), bispectral index, blood concentration of propofol, heart rate (HR) and mean arterial pressure (MAP)
before (pre) and after (hold) clonidine administration and after achieving the pre-BIS-value (post) with possible reduction of propofol in patients
treated with i.v. clonidine or placebo (mean6SD). ²Signi®cant difference from `pre' condition (within-group comparison, after Bonferroni correction,
P<0.017). ³Signi®cant difference from `hold' condition (within-group comparison, after Bonferroni correction, P<0.017). *Signi®cant difference
between groups (after Bonferroni correction, P<0.017).
Table 2 Intra-operative BIS, haemodynamic variables, anaesthetic requirements and the use and dose of gelatin, atropine and ephedrine for haemodynamic
events. Values are mean (SD), absolute counts or median and range. BIS=bispectral index; HR=heart rate; MAP=mean arterial pressure; Prop=intra-operative
propofol infusion rate; Remi=intra-operative remifentanil infusion rate. P<0.05 is signi®cant
Clonidine Placebo P (clonidine vs placebo)
BIS 48 (4) 48 (4) 0.73
HR (beats min±1) 53 (5) 54 (7) 0.46
MAP (mm Hg) 71 (7) 78 (9) 0.01
Target concentration of propofol (mg ml±1) 2.3 (0.4) 2.8 (0.5) <0.01
Prop (mg kg±1 min±1) 0.11 (0.02) 0.13 (0.02) <0.01
Remi (mg kg±1 min±1) 0.14 (0.08) 0.11 (0.08) 0.13
Use of gelatin 10/25 10/25 1
Gelatin (ml) 0 (0±1500) 0 (0±1000) 0.48
Use of atropine 5/25 4/25 0.73
Atropine (mg) 0 (0±1.5) 0 (0±1.0) 0.67
Use of ephedrine 4/25 1/25 0.35
Ephedrine (mg) 0 (0±10) 0 (0/5) 0.16
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of propofol when comparing different phases and the
two groups.
Clonidine did not have any additional effect in reducing
the intra-operative requirement for remifentanil. This is in
agreement with a study by Engelman and colleagues,
describing similar intra-operative opioid requirements with
and without clonidine.18 However, clonidine has been
reported to reduce post-operative opioid requirements.19
Because the primary site of analgesic action of clonidine has
been proposed to be the spinal dorsal horn, it is conceivable
that systemically administered clonidine has a relatively
limited analgesic ef®cacy, enabling modulation of post-
operative pain but being less effective against the more
intense intra-operative pain.20
In summary, the pharmacodynamic effect of i.v. clonidine
can be monitored with the BIS. Intravenous clonidine causes
a signi®cant decrease in the BIS and allows a lower propofol
dose to be used at a similar level of anaesthesia without
intra-operative awareness or prolonged recovery times.
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